Meloxicam Dosing Guidelines

Standard Dosing Regimens

The standard dosing for meloxicam is 7.5 mg once daily, which can be increased to a maximum of 15 mg once daily if needed for adequate symptom control, as recommended by the Annals of the Rheumatic Diseases 1
Maximum dose is 15 mg once daily if the lower dose provides insufficient relief, according to the Annals of the Rheumatic Diseases 1

Meloxicam should not be used continuously for more than 2-4 weeks without reassessment, as prolonged NSAID use significantly increases gastrointestinal, cardiovascular, and renal complications, as stated by Praxis Medical Insights 2
For acute pain conditions: NSAID monotherapy should generally not exceed 1 month, as recommended by Praxis Medical Insights 2
Continuing NSAID monotherapy beyond 2 months is inappropriate for patients with active arthritis, according to Praxis Medical Insights 2

Monitor renal function if treatment extends beyond 2 weeks, particularly in elderly patients or those with existing renal impairment, as advised by Praxis Medical Insights 2
Consider gastroprotection with proton pump inhibitors for patients requiring treatment beyond 2 weeks, as recommended by Praxis Medical Insights 2
Blood pressure monitoring is warranted as NSAIDs can increase blood pressure by approximately 5 mm Hg with continued use, according to Praxis Medical Insights 2

Do not continue monotherapy indefinitely without reassessing the need for alternative or adjunctive therapies, as stated by Praxis Medical Insights 2
Do not ignore cardiovascular risk factors as long-term use increases risk of cardiac ischemic events by 3.5 per 1,000 persons, as advised by Praxis Medical Insights 2

The American Journal of Kidney Diseases recommends that NSAIDs should be avoided in patients with GFR < 30 mL/min/1.73 m² and prolonged therapy is not recommended in those with GFR < 60 mL/min/1.73 m² 3
NSAIDs, such as meloxicam, should be temporarily suspended during intercurrent illness, planned IV radiocontrast administration, bowel preparation, or prior to major surgery, as recommended by the American Journal of Kidney Diseases 3

The American Family Physician recommends considering lower initial doses and slower titration in elderly patients 4
The American Family Physician suggests evaluating gastrointestinal risk factors, including history of ulcer, previous GI bleeding, and use of anticoagulants, before initiating meloxicam 4
The risk of gastrointestinal bleeding increases from 1 in 2,100 in adults under 45 years to 1 in 110 in adults over 75 years, according to the American Family Physician 4
Concomitant use of anticoagulants increases the risk of gastrointestinal bleeding five to six times, as reported by the American Family Physician 4

The American Family Physician recommends a maximum dose of 7.5 mg daily in elderly patients 4

The American Academy of Family Physicians recommends a starting dose of meloxicam for adults, with a dose titration strategy that includes increasing to a maximum of 15 mg once daily if needed for adequate symptom control, with the half-life of meloxicam being approximately 20 hours, requiring consideration for perioperative management 5

The American College of Chest Physicians notes that the half-life of meloxicam is approximately 20 hours, requiring consideration for perioperative management 5

The National Comprehensive Cancer Network recommends considering gastroprotection with proton pump inhibitors for patients requiring meloxicam treatment beyond 2 weeks, and evaluating gastrointestinal risk factors before initiating meloxicam, including history of ulcer, previous GI bleeding, and use of anticoagulants 6
The National Comprehensive Cancer Network suggests that concomitant use of anticoagulants increases the risk of gastrointestinal bleeding five to six times, and well-tolerated proton pump inhibitors are recommended to reduce gastrointestinal side effects induced by NSAIDs 6
History of peptic ulcer disease, advanced age (> 60 years), male gender, and concurrent corticosteroid therapy should be considered before NSAID administration to prevent upper gastrointestinal tract bleeding and perforation, as recommended by the National Comprehensive Cancer Network 6
The National Comprehensive Cancer Network advises to prescribe meloxicam with caution when given with concomitant administration of other nephrotoxic drugs and renally excreted chemotherapy to prevent renal toxicities 6
Patients older than 60 years or with compromised fluid status or renal insufficiency should be prescribed NSAIDs with caution, according to the National Comprehensive Cancer Network 6